跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,168 条关于
“Spartan Capital Securities”
全部
4,168
临床试验
640
药物
17
机构
122
资讯
3,389
9个月前
Lixte Biotechnology Raises $4.3 Million to Advance Cancer Treatment Development
去年
Lixte Biotechnology Secures $5 Million Private Placement to Advance Cancer Therapy Development
去年
NanoViricides Highlights NV-387's Potential in Broad-Spectrum Antiviral Market
去年
Virpax Pharmaceuticals Reports Successful Human Trial of Molecular Envelope Technology with No Severe Adverse Events
去年
Serina Therapeutics and enVVeno Medical Each File $100M Mixed Securities Shelf
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
去年
NLS Pharmaceutics and NewAmsterdam Pharma File Mixed Securities Shelves Worth $75M and $500M Respectively
去年
Brain Navi Partners with First Securities for IPO, Aims to Accelerate Global MedTech Expansion
去年
Iovance CFO Resigns Amid Amtagvi Launch Struggles and Securities Fraud Investigation
去年
Mizuho Securities Maintains Hold Rating on Neurocrine as Osavampator Development Faces Timeline Uncertainties
第 1 页,共 339 页
上一页
下一页